The global CAR T-cell therapy/Chimeric Antigen Receptor T-cell Therapy/T-cell immunotherapy market is experiencing a period of rapid growth/expansion/development. Driven by the success/effectiveness/efficacy of these therapies in treating certain website types of cancer/blood cancers/hematologic malignancies, demand for CAR T-cell therapy is increa